CIK 0000885725
- Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042695240
- Phone
- +1 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-01 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion | +2,062 | 25,067 | ||
| 2022-05-01 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Shares withheld for taxes | −606 | $42.11 | $26K | 24,461 |
| 2022-05-01 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion · Deferred Stock Units | −2,062 | 2,062 | ||
| 2022-02-28 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion | +1,019 | 23,305 | ||
| 2022-02-28 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Shares withheld for taxes | −300 | $44.17 | $13K | 23,005 |
| 2022-02-28 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion · Deferred Stock Units | −1,019 | 0 | ||
| 2022-02-22 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Grant or award · Performance Share Units | +8,283 | 8,283 | ||
| 2022-02-21 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion | +779 | 22,515 | ||
| 2022-02-21 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Shares withheld for taxes | −229 | $42.55 | $10K | 22,286 |
| 2022-02-21 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion · Deferred Stock Units | −779 | 779 | ||
| 2022-02-18 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion | +1,112 | 22,063 | ||
| 2022-02-18 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Shares withheld for taxes | −327 | $42.55 | $14K | 21,736 |
| 2022-02-18 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion · Deferred Stock Units | −1,112 | 2,224 | ||
| 2022-02-17 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion | +1,583 | 21,445 | ||
| 2022-02-17 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Shares withheld for taxes | −494 | $42.83 | $21K | 20,951 |
| 2022-02-17 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion · Restricted Stock Units | −1,583 | 4,750 | ||
| 2022-02-16 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Grant or award · Restricted Stock Units | +8,486 | 8,486 | ||
| 2022-02-16 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Grant or award · Stock Option (Right to Buy) | +24,264 | 24,264 | ||
| 2022-02-15 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Exercise or conversion | +1,108 | 20,250 | ||
| 2022-02-15 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Shares withheld for taxes | −388 | $44.01 | $17K | 19,862 |
Page 1 of 3 · 49 trades